Cargando…

Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis

BACKGROUND: The effects of omega-3 fatty acids (FAs), such as eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids, on cardiovascular outcomes are uncertain. We aimed to determine the effectiveness of omega-3 FAs on fatal and non-fatal cardiovascular outcomes and examine the potential variability...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khan, Safi U., Lone, Ahmad N., Khan, Muhammad Shahzeb, Virani, Salim S., Blumenthal, Roger S., Nasir, Khurram, Miller, Michael, Michos, Erin D., Ballantyne, Christie M., Boden, William E., Bhatt, Deepak L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413259/ https://www.ncbi.nlm.nih.gov/pubmed/34505026 http://dx.doi.org/10.1016/j.eclinm.2021.100997

Ejemplares similares

Meta-Analysis of Contemporary Trials of Omega-3 Fatty Acids Containing Both Eicosapentaenoic and Docosahexaenoic Acids
por: Khan, Safi U., et al.
Publicado: (2021)

Stroke‐Related Mortality in the United States–Mexico Border Area of the United States, 1999 to 2018
por: Khan, Safi U., et al.
Publicado: (2021)

Effects of Influenza Vaccine on Mortality and Cardiovascular Outcomes in Patients With Cardiovascular Disease: A Systematic Review and Meta‐Analysis
por: Yedlapati, Siva H., et al.
Publicado: (2021)

Evaluation of Representation of Women as Authors in Pivotal Trials Supporting US Food and Drug Administration Approval of Novel Cardiovascular Drugs
por: Shahid, Izza, et al.
Publicado: (2022)

Income disparity and utilization of cardiovascular preventive care services among U.S. adults
por: Shahu, Andi, et al.
Publicado: (2021)

Cardiovascular mortality after intensive LDL-Cholesterol lowering: Does baseline LDL-Cholesterol really matter?
por: Khan, Safi U., et al.
Publicado: (2020)

Demographic, Regional, and State‐Level Trends of Mortality in Patients With Aortic Stenosis in United States, 2008 to 2018
por: Khan, Safi U., et al.
Publicado: (2020)

Participation of Women and Older Participants in Randomized Clinical Trials of Lipid-Lowering Therapies: A Systematic Review
por: Khan, Safi U., et al.
Publicado: (2020)

Dual Antiplatelet Therapy After Percutaneous Coronary Intervention and Drug-Eluting Stents: A Systematic Review and Network Meta-Analysis
por: Khan, Safi U., et al.
Publicado: (2020)

Association Between Omega‐3 Fatty Acid Levels and Risk for Incident Major Bleeding Events and Atrial Fibrillation: MESA
por: Kapoor, Karan, et al.
Publicado: (2021)

Mapping and quantification of the twitter footprint of cardiologists
por: Kalra, Ankur, et al.
Publicado: (2021)

Mental health disorders among patients with acute myocardial infarction in the United States
por: Sreenivasan, Jayakumar, et al.
Publicado: (2020)

Nondietary Cardiovascular Health Metrics With Patient Experience and Loss of Productivity Among US Adults Without Cardiovascular Disease: The Medical Expenditure Panel Survey 2006 to 2015
por: Tibuakuu, Martin, et al.
Publicado: (2020)

Trends in Premature Mortality From Acute Myocardial Infarction in the United States, 1999 to 2019
por: Dani, Sourbha S., et al.
Publicado: (2021)

Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease
por: Mahtta, Dhruv, et al.
Publicado: (2020)

Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid
por: Mason, R. Preston, et al.
Publicado: (2020)

Racial and geographic disparities in influenza vaccination in the U.S. among individuals with atherosclerotic cardiovascular disease: Renewed importance in the setting of COVID-19
por: Al Rifai, Mahmoud, et al.
Publicado: (2021)

Omega‐3 Fatty Acids (Fish Oil) Supplementation and Albuminuria: Not a Slam Dunk
por: Navaneethan, Sankar D., et al.
Publicado: (2017)

The Kardashian Index of Cardiologists: Celebrities or Experts?
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2020)

Clinical and Economic Burden of Stroke Among Young, Midlife, and Older Adults in the United States, 2002-2017
por: Khan, Safi U., et al.
Publicado: (2021)

Gender Differences in Patient‐Reported Outcomes Among Adults With Atherosclerotic Cardiovascular Disease
por: Okunrintemi, Victor, et al.
Publicado: (2018)

Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues
por: Sherratt, Samuel C. R., et al.
Publicado: (2022)

Communication approaches to enhance patient motivation and adherence in cardiovascular disease prevention
por: Duffy, Eamon Y., et al.
Publicado: (2021)

PCSK9 Inhibitors in the Management of Cardiovascular Risk: A Practical Guidance
por: Jia, Xiaoming, et al.
Publicado: (2022)

Shared decision making and patient reported outcomes among adults with atherosclerotic cardiovascular disease, medical expenditure panel survey 2006–2015
por: Okunrintemi, Victor, et al.
Publicado: (2021)

Disparities in Influenza Vaccination Coverage and Associated Factors Among Adults with Cardiovascular Disease, United States, 2011–2020
por: Parekh, Tarang, et al.
Publicado: (2022)

Social Determinants of Suboptimal Cardiovascular Health Among Pregnant Women in the United States
por: Sharma, Garima, et al.
Publicado: (2022)

Sex Differences in the Age of Diagnosis for Cardiovascular Disease and Its Risk Factors Among US Adults: Trends From 2008 to 2017, the Medical Expenditure Panel Survey
por: Okunrintemi, Victor, et al.
Publicado: (2020)

Life's Simple 7 and Incident Heart Failure: The Multi‐Ethnic Study of Atherosclerosis
por: Ogunmoroti, Oluseye, et al.
Publicado: (2017)

Vaccines and cardiovascular outcomes: lessons learned from influenza epidemics
por: Yedlapati, Siva H, et al.
Publicado: (2023)

Family income and cardiovascular disease risk in American adults
por: Minhas, Abdul Mannan Khan, et al.
Publicado: (2023)

Ten‐Year Trends in Enrollment of Women and Minorities in Pivotal Trials Supporting Recent US Food and Drug Administration Approval of Novel Cardiometabolic Drugs
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2020)

Age-specific differences in patient reported outcomes among adults with atherosclerotic cardiovascular disease: Medical expenditure panel survey 2006–2015
por: Okunrintemi, Victor, et al.
Publicado: (2020)

Reply: The Social Media Kardashian Index: A Stagnant Measure for an Innovative Platform
por: Michos, Erin D., et al.
Publicado: (2020)

Spotlight on Icosapent Ethyl for Cardiovascular Risk Reduction: Evidence to Date
por: Jia, Xiaoming, et al.
Publicado: (2020)

Cardiovascular Disease Mortality Among Hispanic Versus Non‐Hispanic White Adults in the United States, 1999 to 2018
por: Khan, Safi U., et al.
Publicado: (2022)

Social vulnerability and COVID-19: An analysis of CDC data
por: Al Rifai, Mahmoud, et al.
Publicado: (2022)

Same evidence, varying viewpoints: Three questions illustrating important differences between United States and European cholesterol guideline recommendations
por: Feldman, David I., et al.
Publicado: (2020)

High‐Sensitivity C‐Reactive Protein Discordance With Atherogenic Lipid Measures and Incidence of Atherosclerotic Cardiovascular Disease in Primary Prevention: The ARIC Study
por: Quispe, Renato, et al.
Publicado: (2020)

A dataset to assess providers׳ knowledge and attitudes towards the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline
por: Pokharel, Yashashwi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_efplrldaun45qco1aeun9442a0